February 1, 2026 · Form 4 insider transaction
Lewicki John A. bought 145,000 shares of MEREO BIOPHARMA GROUP PLC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.; Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.